Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-001104
Accepted
2024-04-25 00:15:10
Documents
1
Effectiveness Date
2024-04-24
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-24-001104.txt   1965
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-277753 | Film No.: 24872631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)